Contents
pdf Download PDF
pdf Download XML
53 Views
15 Downloads
Share this article
Review Article | Volume 11 Issue 10 (October, 2025) | Pages 381 - 392
Under a Creative Commons license
Open Access
Received
Sept. 2, 2025
Revised
Sept. 19, 2025
Accepted
Oct. 3, 2025
Published
Oct. 15, 2025
Abstract
Background: Sudden cardiac death (SCD) in young individuals often results from rare cardiovascular disorders that present significant challenges in forensic pathology. Understanding the autopsy findings, diagnostic limitations, and legal implications is crucial for improving death investigation practices and family care. Objective: To systematically review the literature on forensic autopsy findings, diagnostic challenges, and legal implications associated with sudden cardiac death caused by rare cardiovascular disorders. Methods: A comprehensive systematic literature review was conducted following PRISMA 2020 guidelines. We searched SciSpace, PubMed, Google Scholar, and other databases from 2010 to 2025. Studies were included if they reported on sudden cardiac death cases involving rare cardiovascular disorders with forensic autopsy findings, diagnostic challenges, or legal implications. Data extraction focused on autopsy findings, diagnostic techniques, genetic testing results, and medicolegal aspects. Results: From 240 initially identified papers, 227 unique studies remained after deduplication. The literature revealed that rare cardiovascular disorders including arrhythmogenic cardiomyopathies, ion channelopathies, and inherited cardiomyopathies account for a significant proportion of SCD in young individuals. Molecular autopsy identifies pathogenic variants in approximately 20-25% of unexplained SCD cases. Key diagnostic challenges include negative autopsy findings, limited access to specialized testing, and inconsistent tissue handling protocols. Legal implications encompass family screening obligations, insurance considerations, and expert testimony requirements. Conclusions: Forensic investigation of SCD requires standardized protocols incorporating molecular autopsy, multidisciplinary expertise, and systematic family follow-up. Significant gaps exist in diagnostic standardization, genetic counseling implementation, and legal frameworks. Enhanced training, resource allocation, and policy development are needed to optimize forensic practice and family care in rare cardiovascular disorder-related SCD.
Keywords
Recommended Articles
Research Article
Background: Postoperative pain following cardiac surgeries, including coronary artery bypass grafting (CABG), can range from mild to severe and significantly hinder early mobility and functional recovery. Traditionally, opioid analgesics have been the mainstay of pain management, but their use is associated with various undesirable side effects. Multimodal pain management (MM-PM) has emerged as a promising alternative to reduce opioid use and improve pain control, involving a combination of different analgesic agents to target various pain pathways. Method: This prospective observational study was conducted at the Pacific Institute of Medical Sciences, Udaipur, from April 2023 to March 2025. A total of 100 patients aged 45-75 years undergoing elective cardiac surgeries, including CABG, were randomly assigned to two groups. Group 1 received multimodal pain management (opioids, NSAIDs, local anesthetics), and Group 2 received standard opioid-based pain management. Data on postoperative pain scores, opioid consumption, recovery parameters, complications, and patient satisfaction were collected at 24 and 72 hours post-surgery. Results: The MM-PM group reported significantly lower pain scores at 24 and 72 hours compared to the standard group (p<0.001). The MM-PM group also consumed fewer opioids (22 mg vs. 37 mg, p<0.001), had faster extubation times, shorter ICU stays, and reduced hospital stays. The incidence of nausea and vomiting was lower in the MM-PM group (12% vs. 28%, p=0.045). Additionally, patient satisfaction scores were significantly higher in the MM-PM group (8.7 vs. 6.9, p<0.001). Conclusion: Multimodal pain management following cardiac surgery effectively reduces postoperative pain, decreases opioid consumption, accelerates recovery, and improves patient satisfaction. These findings support the use of MM-PM as a standard approach in postoperative care for cardiac surgery patients to minimize opioid-related side effects and optimize recovery.
Published: 15/10/2025
Research Article
A Study Evaluating the Effectiveness of Multimodal Pain Management in Reducing Postoperative Pain and Accelerating Recovery after Cardiac Surgery
...
Published: 15/10/2025
Research Article
Early Diagnostic Value of Biochemical and Hematological Parameters in Hepatitis C Virus Infection
...
Published: 15/10/2025
Research Article
MRI evaluation of symptomatic pelvic floor weakness in females
Published: 15/10/2025
Chat on WhatsApp
© Copyright Journal of Contemporary Clinical Practice